Senhwa Biosciences

Senhwa Biosciences, Inc. is a clinical-stage drug development company focused on next-generation DNA Damage Response (DDR) therapies for cancer. Senhwa has a strong management team with a proven track record in developing novel and targeted therapeutics. Headquartered in Taiwan, with a significant operational base in San Diego, California, the Senhwa team is well-positioned to oversee the development of their compounds through collaboration with various global investigators and service providers.